Letrozole plus Simvastatin versus Letrozole in Denovo Metastatic HER2/neu Negative Luminal Breast Cancer: A phase II Randomized Controlled Trial
(2025). Letrozole plus Simvastatin versus Letrozole in Denovo Metastatic HER2/neu Negative Luminal Breast Cancer: A phase II Randomized Controlled Trial. EKB Journal Management System, 13(2), 105-116.
. "Letrozole plus Simvastatin versus Letrozole in Denovo Metastatic HER2/neu Negative Luminal Breast Cancer: A phase II Randomized Controlled Trial". EKB Journal Management System, 13, 2, 2025, 105-116.
(2025). 'Letrozole plus Simvastatin versus Letrozole in Denovo Metastatic HER2/neu Negative Luminal Breast Cancer: A phase II Randomized Controlled Trial', EKB Journal Management System, 13(2), pp. 105-116.
Letrozole plus Simvastatin versus Letrozole in Denovo Metastatic HER2/neu Negative Luminal Breast Cancer: A phase II Randomized Controlled Trial. EKB Journal Management System, 2025; 13(2): 105-116.